No Prescription » Prescription Drugs 4 » CLAVAM Co Amoxiclav
The combination of amoxicillin and clavulanic acid is used to treat certain infections caused by bacteria including infections of the ears lungs sinus skin and urinary tract. Amoxicillin is in a class of medications called penicillin-like antibiotics. It works by stopping the growth of bacteria. Clavulanic acid is in a class of medications called beta-lactamase inhibitors. It works by preventing bacteria from destroying amoxicillin. Antibiotics will not work for colds flu or other viral infections.The combination of amoxicillin and clavulanic acid comes as a tablet a chewable tablet and a suspension (liquid) to take by mouth. It is usually taken with a meal or a snack every 8 hours (three times a day) or every 12 hours (twice a day). To help you remember to take amoxicillin and clavulanate take it around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take amoxicillin and clavulanic acid exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Shake the liquid well before each use to mix the medication evenly.The chewable tablets should be chewed thoroughly before they are swallowed. The other tablets should be taken with a full glass of water.The 250 mg and 500 mg tablets of amoxicillin and clavulanic acid contain the same amount of clavulanic acid. Do not substitute two 250 mg tablets for one 500 mg tablet. The 250 mg regular tablet and the 250 mg chewable tablet contain different amounts of clavulanic acid. They also should not be substituted.Take amoxicillin and clavulanic acid until you finish the prescription even if you feel better. Stopping amoxicillin and clavulanic acid too soon may cause bacteria to become resistant to antibiotics.
Buy CLAVAM Co Amoxiclav and other Prescription Drugs 4 products online
at Medstore.
Buy Online at Medstore - Click Here!

About CLAVAM Co Amoxiclav:
Product Type: Prescription Drugs 4
CLAVAM ( Co-Amoxiclav Augmentin Generic Amoxycillin/clavulanic acid )
CLAVAM (Co-Amoxiclav Augmentin Generic Amoxycillin/clavulanic acid)
Co-Amoxiclav Augmentin Generic Amoxycillin/clavulanic acid
375mg Tabs 30 (3 x 10) 625mg Tabs 30 (3 x 10)
Co-Amoxiclav Augmentin Generic Amoxycillin/clavulanic acid CLAVAM

View more
Prescription Drugs 4
Previous Product Next Product
No Prescription:
NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.


|